Network-Based In Silico Analysis of New Combinations of Modern Drug Targets with Methotrexate for Response-Based Treatment of Rheumatoid Arthritis

Background: Methotrexate (MTX), sulfonamides, hydroxychloroquine, and leflunomide have consistently resulted in remission with relatively mild to moderate adverse effects in patients with rheumatoid arthritis (RA). Modern medications outperform traditional treatments in that they target the patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Assefi, Marjan, Lewandrowski, Kai-Uwe, Lorio, Morgan, Fiorelli, Rossano Kepler Alvim, Landgraeber, Stefan, Sharafshah, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672378/
https://www.ncbi.nlm.nih.gov/pubmed/38003865
http://dx.doi.org/10.3390/jpm13111550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672378/
https://www.ncbi.nlm.nih.gov/pubmed/38003865
http://dx.doi.org/10.3390/jpm13111550

Ejemplares similares